CME Group (NASDAQ:CME) Shares Acquired Rep. Carol D. Miller

Representative Carol D. Miller (R-West Virginia) recently bought shares of CME Group Inc. NASDAQ: CME. In a filing disclosed on April 11th, the Representative disclosed that they had bought between $1,001 and $15,000 in CME Group stock on March 10th. The trade occurred in the Representative's "MATT MILLER INVESTMENT MANAGEMENT ACCOUNT" account.

Representative Carol D. Miller also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Aflac NYSE: AFL on 3/10/2025.
• Purchased $1,001 - $15,000 in shares of Hershey NYSE: HSY on 3/10/2025.
• Purchased $1,001 - $15,000 in shares of Gilead Sciences NASDAQ: GILD on 3/10/2025.
• Sold $1,001 - $15,000 in shares of Pfizer NYSE: PFE on 3/10/2025.
• Purchased $1,001 - $15,000 in shares of Lockheed Martin NYSE: LMT on 3/10/2025.
• Purchased $1,001 - $15,000 in shares of PepsiCo NASDAQ: PEP on 3/10/2025.
• Purchased $1,001 - $15,000 in shares of Honeywell International NASDAQ: HON on 3/10/2025.
• Sold $1,001 - $15,000 in shares of U.S. Bancorp NYSE: USB on 3/10/2025.
• Sold $1,001 - $15,000 in shares of Target NYSE: TGT on 3/10/2025.
• Purchased $1,001 - $15,000 in shares of American Water Works NYSE: AWK on 3/10/2025.

CME Group Trading Up 0.4 %

Shares of NASDAQ:CME traded up $1.14 on Friday, hitting $262.53. 1,794,607 shares of the company's stock were exchanged, compared to its average volume of 2,144,707. The stock has a market capitalization of $94.60 billion, a price-to-earnings ratio of 27.15, a price-to-earnings-growth ratio of 6.76 and a beta of 0.43. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $273.42. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The business's 50 day simple moving average is $257.19 and its two-hundred day simple moving average is $240.53.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, topping analysts' consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. Analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were paid a dividend of $1.25 per share. This is a positive change from CME Group's previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.90%. The ex-dividend date of this dividend was Friday, March 7th. CME Group's dividend payout ratio (DPR) is currently 51.71%.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Erste Group Bank raised CME Group to a "strong-buy" rating in a research report on Monday, March 17th. Oppenheimer lifted their target price on CME Group from $269.00 to $279.00 and gave the company an "outperform" rating in a research note on Friday, April 11th. JPMorgan Chase & Co. increased their price target on shares of CME Group from $209.00 to $212.00 and gave the company an "underweight" rating in a research report on Thursday, February 13th. Citigroup downgraded shares of CME Group from a "buy" rating to a "neutral" rating and cut their price objective for the stock from $255.00 to $250.00 in a research report on Monday, January 6th. Finally, Bank of America raised their target price on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research note on Wednesday, April 2nd. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $247.47.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. SeaCrest Wealth Management LLC lifted its holdings in shares of CME Group by 3.0% in the 1st quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock valued at $366,000 after buying an additional 40 shares during the period. New Age Alpha Advisors LLC grew its stake in shares of CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares during the period. Avidian Wealth Enterprises LLC lifted its stake in shares of CME Group by 2.6% in the 4th quarter. Avidian Wealth Enterprises LLC now owns 1,769 shares of the financial services provider's stock valued at $411,000 after purchasing an additional 45 shares during the period. TFC Financial Management Inc. boosted its holdings in CME Group by 8.4% during the fourth quarter. TFC Financial Management Inc. now owns 592 shares of the financial services provider's stock worth $137,000 after buying an additional 46 shares in the last quarter. Finally, Waldron Private Wealth LLC grew its position in CME Group by 2.0% during the fourth quarter. Waldron Private Wealth LLC now owns 2,362 shares of the financial services provider's stock valued at $549,000 after buying an additional 47 shares during the period. Hedge funds and other institutional investors own 87.75% of the company's stock.

Insiders Place Their Bets

In other news, COO Suzanne Sprague sold 1,500 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the transaction, the chief operating officer now owns 8,036 shares in the company, valued at $2,063,885.88. This trade represents a 15.73 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Julie Winkler sold 11,592 shares of the business's stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the sale, the insider now directly owns 21,885 shares of the company's stock, valued at approximately $5,453,085.45. The trade was a 34.63 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 27,076 shares of company stock worth $6,871,496. Company insiders own 0.30% of the company's stock.

About Representative Miller

Carol Miller (Republican Party) is a member of the U.S. House, representing West Virginia's 1st Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. Miller (Republican Party) ran for re-election to the U.S. House to represent West Virginia's 1st Congressional District. She won in the general election on November 5, 2024. West Virginia's 3rd Congressional District race was identified as a 2018 battleground that might have affected partisan control of the U.S. House in the 116th Congress. Incumbent Evan Jenkins (R) did not seek re-election in 2018, leaving the seat open. In the campaign, Miller emphasized her endorsement by President Donald Trump (R). Lara Trump, Senior Advisor to Donald J. Trump for President, Inc., said, "Carol is pro-coal, pro-Second Amendment, and pro-Trump through and through, and is prepared to tackle the opioid epidemic that’s affected countless West Virginians." Miller also supported the construction of a wall on the southern U.S. border and the Tax Cuts and Jobs Act (TCJA). Miller is a former Republican member of the West Virginia House of Delegates, representing District 16 from 2006 to 2018. Miller has also worked in real estate and owns a bison farm. Carol Miller was born in Columbus, Ohio. Miller graduated from Bexley High School in 1968. She earned a B.S. from Columbia College in 1972. Her career experience includes owning and operating Swann Ridge Bison Farm and working as a real estate manager.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.